Tanaka Maho, Kojima Yasushi, Nishimura Takahiro, Numazawa Satoshi, Momo Kenji
Department of Pharmacy National Center for Global Health and Medicine Tokyo Japan.
Department of Toxicology Showa Medical University Graduate School of Pharmacy Tokyo Japan.
Clin Case Rep. 2025 Aug 25;13(9):e70800. doi: 10.1002/ccr3.70800. eCollection 2025 Sep.
Although the treatment strategies differ significantly, metronidazole-induced encephalopathy and delirium manifest with similar clinical symptoms. Therefore, the potential risk of encephalopathy should be considered when treating patients with delirium.
尽管治疗策略差异显著,但甲硝唑诱发的脑病和谵妄表现出相似的临床症状。因此,在治疗谵妄患者时应考虑脑病的潜在风险。